HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zandomeni, R. O. Articles by Ferrer, J. F. Search for Related Content PubMed PubMed Citation Articles by Zandomeni, R. O. Articles by Ferrer, J. F. Agricola Articles by Zandomeni, R. O. Articles by Ferrer, J. F.

Induction and inhibition of bovine leukaemia virus expression in naturally infected cells

School of Veterinary Medicine, University of Pennsylvania, New Bolton Center, 382 West Street Road, Kennett Square, Pennsylvania 19348, U.S.A.

Bovine leukaemia virus (BLV) resides in infected lymphocytes in a latent, repressed state but becomes expressed a few hours after the cells are cultured in vitro. We have identified several conditions and factors affecting the expression of BLV in short-term cultures of naturally infected lymphoid cells. The presence of foetal calf serum in the culture medium greatly stimulates virus expression. This stimulation is not due to cellular proliferation. Transcription of BLV RNA and synthesis of p25 in the cultures of peripheral blood lymphocytes are preceded by a lag period of several hours. Synthesis of BLV p25 in these cultures takes place almost immediately after viral RNA synthesis. Extending previous results, we demonstrate that the plasma and lymphatic fluid of cattle contain factors that suppress and stimulate BLV expression. As a result of systematic examination of several parameters, we have developed reproducible assays for the detection of these factors. It is very likely that their relative concentration in the host is an important determinant of susceptibility and resistance to the development of lymphosarcoma and persistent lymphocytosis in BLV-infected cattle.

Received 30 December 1991; accepted 1 April 1992.

This article has been cited by other articles:

				T. L.-A. Nguyen, S. de Walque, E. Veithen, A. Dekoninck, V. Martinelli, Y. de Launoit, A. Burny, R. Harrod, and C. Van Lint Transcriptional Regulation of the Bovine Leukemia Virus Promoter by the Cyclic AMP-response Element Modulator {tau} Isoform J. Biol. Chem., July 20, 2007; 282(29): 20854 - 20867. [Abstract] [Full Text] [PDF]

				M. J. van den Heuvel, B. J. Jefferson, and R. M. Jacobs Isolation of a Bovine Plasma Fibronectin-Containing Complex Which Inhibits the Expression of Bovine Leukemia Virus p24 J. Virol., July 1, 2005; 79(13): 8164 - 8170. [Abstract] [Full Text] [PDF]

				W. A. Ferens and C. J. Hovde Antiviral Activity of Shiga Toxin 1: Suppression of Bovine Leukemia Virus-Related Spontaneous Lymphocyte Proliferation Infect. Immun., August 1, 2000; 68(8): 4462 - 4469. [Abstract] [Full Text] [PDF]

				J. Xiao and G. C. Buehring In Vivo Protein Binding and Functional Analysis of cis-Acting Elements in the U3 Region of the Bovine Leukemia Virus Long Terminal Repeat J. Virol., July 1, 1998; 72(7): 5994 - 6003. [Abstract] [Full Text] [PDF]